Aimmune is the second initial public offering of stock this week from the Bay Area read more
Aimmune Therapeutics CEO & Leadership Team Ratings
Dr. Jayson Dallas and the Aimmune Therapeutics leadership team are scored an "A+" by 6 employees placing it in the Top 5% of companies sized 1-10 Employees on Comparably. The Leadership Score of 91/100 is based on 25 ratings; it combines employee feedback on their CEO (85/100), Manager (91/100), and Executive Team (84/100).
Dr. Jayson Dallas Aimmune Therapeutics CEO Rating
Top 5% Compared to other companies of similar size in San FranciscoA+
85 / 100
Dr. Jayson Dallas the CEO of Aimmune Therapeutics received an average score of 85 from Aimmune Therapeutics employees.Aimmune Therapeutics Manager Rating
Top 5% Compared to other companies of similar size in San FranciscoA+
91 / 100
Aimmune Therapeutics Executive Team Rating
Top 5% Compared to other companies of similar size in San FranciscoA+
84 / 100
×